|  |
| |
| |
| |
| |
 |  |  |  |  |
    |
| PR:Q5D0E6 | DALR anticodon-binding domain-containing protein 3 (human) | | |  | | |
 |  |  |  |  |  |
    |
| PR:000070786 | DALR anticodon-binding domain-containing protein 3 citrullinated 1 (human) | | |  | | |
 |  |  |  |  |  |
    |
| PR:000069153 | DALR anticodon-binding domain-containing protein 3 cysteinylated 1 (human) | | |  | | |
 |  |  |  |  |  |
    |
| PR:000078729 | DALR anticodon-binding domain-containing protein 3 cysteinylated 2 (human) | | |  | | |
 |  |  |  |  |  |
    |
| PR:Q5D0E6-1 | DALR anticodon-binding domain-containing protein 3 isoform h1 (human) | | |  | | |
 |  |  |  |  |  |
    |
| PR:Q5D0E6-2 | DALR anticodon-binding domain-containing protein 3 isoform h2 (human) | | |  | | |
 |  |  |  |  |  |
    |
| PR:Q5D0E6-3 | DALR anticodon-binding domain-containing protein 3 isoform h3 (human) | | |  | | |
 |  |  |  |  |  |
    |
| PR:Q5D0E6-4 | DALR anticodon-binding domain-containing protein 3 isoform h4 (human) | | |  | | |
 |  |  |
    |
| PR:000031291 | DALR anticodon-binding domain-containing protein 3 | | |  | | |
 |  |  |  |
    |
| PR:Q5D0E6 | DALR anticodon-binding domain-containing protein 3 (human) | | |  | | |
 |  |  |  |  |
    |
| PR:000070786 | DALR anticodon-binding domain-containing protein 3 citrullinated 1 (human) | | |  | | |
 |  |  |  |  |
    |
| PR:000069153 | DALR anticodon-binding domain-containing protein 3 cysteinylated 1 (human) | | |  | | |
 |  |  |  |  |
    |
| PR:000078729 | DALR anticodon-binding domain-containing protein 3 cysteinylated 2 (human) | | |  | | |
 |  |  |  |  |
    |
| PR:Q5D0E6-1 | DALR anticodon-binding domain-containing protein 3 isoform h1 (human) | | |  | | |
 |  |  |  |  |
    |
| PR:Q5D0E6-2 | DALR anticodon-binding domain-containing protein 3 isoform h2 (human) | | |  | | |
 |  |  |  |  |
    |
| PR:Q5D0E6-3 | DALR anticodon-binding domain-containing protein 3 isoform h3 (human) | | |  | | |
 |  |  |  |  |
    |
| PR:Q5D0E6-4 | DALR anticodon-binding domain-containing protein 3 isoform h4 (human) | | |  | | |